Quantcast
Last updated on April 21, 2014 at 10:25 EDT

Latest Chronic obstructive pulmonary disease Stories

2014-02-12 23:26:12

2nd Annual Conference of Chronic Obstructive Pulmonary Disease (COPD 2014) will be held for the second time this year in Hilton Convention & Exhibition Center, Istanbul between the 7th and 10th March. (PRWEB) February 12, 2014 COPD 2014 will be held for the second time this year in Hilton Convention & Exhibition Center, Istanbul between the 7th and 10th March. As Chronic Obstructive Pulmonary Disease is becoming more and more prevalent in our lives, the latest researches and the...

2014-02-11 08:33:38

StemGenex is now providing access to its latest stem cell therapy for patients diagnosed with COPD through nebulized stem cells. These treatments are being studied with expertise by board certified MD's in the United States. LA JOLLA, Calif., Feb. 11, 2014 /PRNewswire/ -- StemGenex®, the leading resource for adult adipose stem cell therapy in the US aimed at improving the lives of patients dealing with degenerative diseases, today announced the newest therapy to assist patients...

2014-02-11 08:30:39

KONTICH, Belgium, February 11, 2014 /PRNewswire/ -- The Flemish agency for Innovation by Science and Technology (IWT) has awarded a consortium led by the Belgian-based company FLUIDDA a grant of 1MEUR to conduct research to increase survival rates after lung transplantation through Functional Respiratory Imaging (FRI). The international consortium includes, besides FLUIDDA and its long-term research partner Materialise (Leuven, Belgium), also the University of Antwerp...

2014-01-23 04:21:29

OXFORD, England, January 23, 2014 /PRNewswire/ -- First clinical data from PSX1002, a novel, orally inhaled, drug-only, pMDI suspension formulation of glycopyrronium bromide, a long-acting muscarinic antagonist (LAMA) Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, announces positive top-line results from its Phase 2 clinical study with...

2014-01-17 00:21:50

WASHINGTON, Jan. 17, 2014 /PRNewswire-USNewswire/ -- The following is Statement of Matthew L. Myers, President, Campaign for Tobacco-Free Kids: (Logo: http://photos.prnewswire.com/prnh/20080918/CFTFKLOGO) Fifty years after the first Surgeon General's report on smoking and health, the new Surgeon General's report released today shows that cigarette smoking is even more hazardous than previously thought. This report documents that smoking causes even more diseases, kills even more people and...

2014-01-14 12:26:46

BETHESDA, Md., Jan. 14, 2014 /PRNewswire/ -- Evidera, a leading provider of evidence-based solutions for the healthcare industry, announced that the Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration, has released its first draft qualification guidance document for a patient-reported outcome (PRO) measure in drug development: Qualification of Exacerbations of Chronic Pulmonary Disease Tool [EXACT] for Measurement of Symptoms of Acute Bacterial...

2014-01-13 23:02:17

The Alpha-1 Project, a venture philanthropy company created to speed development of new therapies and potential cures for lung and liver diseases caused by Alpha-1 Antitrypsin Deficiency, announced a partnership today with Poliwogg, an innovative financial firm transforming healthcare investing. San Francisco, Calif. (PRWEB) January 13, 2014 The Alpha-1 Project, a venture philanthropy company created to speed development of new therapies and potential cures for lung and liver diseases...

2014-01-13 16:25:12

-- Ultibro(TM) Breezhaler®1(QVA149), a long-term once-daily dual bronchodilator, received Health Canada approval on December 23rd 2013 for the treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema -- Pivotal Phase III IGNITE data showed QVA149 significantly improved lung function and patient-reported outcomes including...

Odor Receptors Found In Lungs
2014-01-03 10:22:27

Brett Smith for redOrbit.com - Your Universe Online New research published in the American Journal of Respiratory Cell and Molecular Biology has revealed that odor receptors aren’t just found in the nose – they also line the lungs as well. However, instead of being used to detect the aroma of blueberry cobbler or a succulent roasting chicken, the odor receptors in the lungs trigger a response designed to protect the airways. “We forget,” said study author Yehuda Ben-Shahar,...

2013-12-17 08:29:39

--Last patient dosed in moderate asthma trial and first patient dosed in COPD study-- QUEBEC CITY, Dec. 17, 2013 /PRNewswire/ -- Asmacure Ltee today announced that the company has completed dosing in a Phase 2 trial evaluating its lead compound, ASM-024, in moderate asthma patients, with data anticipated in the first quarter of 2014. The company also has begun patient enrollment in a Phase 2 trial of ASM-024 in patients with moderate and severe chronic obstructive pulmonary disease...